Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114931) titled 'Safety Study of Leucine-Restricted Diet in Gastric Cancer Patients' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Gastric cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Experimental Group:37;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300955
Published by HT Digital Content Services with permission from Health Daily Digest....